comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 13:04:11 - browse：3673

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Medicare Advantage's lean provider networks lead CMS complaints

WSS

Data don't support strong claims for Covid

Illumina board agrees to spin off Grail, as divestment plans proceed

FDA advisers back CAR

UCLA team creates talking throat patch for voice disorders

ASCO Daily Recap: CAR

Steward Health Care Massachusetts hospitals face fiscal disaster

focus

comprehensive

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: CAR

Medical leaders decry Supreme Court decision on affirmative action

BD to buy Edwards patient monitoring unit for $4.2 billion

The high cost of giving birth even with insurance

FTC loses bid to block Novant's North Carolina hospital merger

As demand for Covid shots wanes, Moderna seeks its next success

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Medicare proposal to cover medical devices draws a mixed reaction

John Green on his newest strategy for fighting tuberculosis

entertainment

CMS got Medicare Advantage quality rating wrong, judge rules

Amid AI frenzy, a top HHS official's quest to create safeguards

Boston's new lab space is opening empty

EPA limits use of carcinogenic gas for sterilizing medical devices

Stopping antidepressants leads to symptoms for 1 in 6 patients

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

explore

leisure time

explore

hotspot